Cargando…
Urine metabolomics as a predictor of patient tolerance and response to adjuvant chemotherapy in colorectal cancer
Colorectal cancer is the third leading cause of cancer-associated mortality in the western world. The ability to predict a patient's response to chemotherapy may be of great value for clinicians and patients when planning cancer treatment. The aim of the current study was to develop a urine met...
Autores principales: | Dykstra, Mark A., Switzer, Noah, Eisner, Roman, Tso, Victor, Foshaug, Rae, Ismond, Kathleen, Fedorak, Richard, Wang, Haili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666654/ https://www.ncbi.nlm.nih.gov/pubmed/29142749 http://dx.doi.org/10.3892/mco.2017.1407 |
Ejemplares similares
-
Development and Validation of a High-Throughput Mass Spectrometry Based Urine Metabolomic Test for the Detection of Colonic Adenomatous Polyps
por: Deng, Lu, et al.
Publicado: (2017) -
A Machine-Learned Predictor of Colonic Polyps Based on Urinary Metabolomics
por: Eisner, Roman, et al.
Publicado: (2013) -
Metabolomic Profiles Are Gender, Disease and Time Specific in the Interleukin-10 Gene-Deficient Mouse Model of Inflammatory Bowel Disease
por: Tso, Victor K., et al.
Publicado: (2013) -
Development and Validation of a Highly Sensitive Urine-Based Test to Identify Patients with Colonic Adenomatous Polyps
por: Wang, Haili, et al.
Publicado: (2014) -
The Human Urine Metabolome
por: Bouatra, Souhaila, et al.
Publicado: (2013)